mirdametinib
Commercial- Indications
- Cancer
Company intelligence / Profile preview
Onco360 provides nationwide specialty pharmacy dispensing and clinical support for cancer patients. It partners with pharmaceutical companies to distribute limited-distribution oncology drugs such as ripretinib for GIST and danicopan for PNH. The company offers comprehensive patient support including financial assistance sourcing, insurance benefit verification, expert clinical counseling, digital tools, and personalized care from board-certified oncology pharmacists. No drug development or clinical trial results are reported since it does not develop therapeutics.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onco360.